Jubilant Pharma completes stake sale in Sofie Biosciences BSE India Jun 6, 2024 Merger with Trilantic Capital Partners leads to strategic disinvestment Jubilant Pharma (JPL), has finalised the sale of its…
Jubilant Pharma to sell its 25.8 per cent stake in Sofie Biosciences for $139.43 mn EP News Bureau Jan 30, 2024 Of this, $113.63 million is expected to be received upon completion of the merger while receipt of balance sum of $25.8 million is…
